News

Filter

Current filters:

Arixtra

1 to 9 of 76 results

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Aspen Pharma reports rise in profits from new product launches

11-09-2013

South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Sanofi-Aventis' Lovenox favored by US medics for VTE primary prophylaxis

24-03-2011

More than 50% of surveyed US orthopedic surgeons and 70% of surveyed managed care organizations’…

ArixtraCardio-vascularEliquisLovenoxMarkets & MarketingPharmaceuticalPradaxaXarelto

Alchemia gets milestone on fondaparinux

22-12-2008

Australian drug developer Alchemia has announced the achievement of a significant milestone towards the…

ArixtrafondaparinuxGlaxoSmithKlineGSK

1 to 9 of 76 results

COMPANY SPOTLIGHT

Menarini

Back to top